A peptide biosensor for detecting intracellular Abl kinase activity using matrix-assisted laser desorption/ionization

Ekaterina A Placzek1, Michael P Plebanek, Andrew M Lipchik

  • 1Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Center for Cancer Research, Purdue University, West Lafayette, IN 47904, USA.

Analytical Biochemistry
|October 13, 2009
PubMed

Insights

Researchers developed a novel biosensor to detect Abl kinase activity and drug response in cancer cells. This tool addresses limitations in multiplexing kinase activity detection and aids in understanding drug resistance mechanisms.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cancer often involves dysregulated kinase activity, exemplified by Bcr-Abl in chronic myeloid leukemia (CML).
  • Kinase inhibitor drugs like imatinib are effective but face challenges with acquired resistance due to long-term use.
  • Current methods for detecting kinase activity often lack multiplexing capabilities, limiting simultaneous substrate analysis.

Purpose of the Study:

  • To develop a novel biosensor for detecting Abl kinase activity in live cells.
  • To assess the sensitivity of Abl kinase activity to inhibitor drugs using the biosensor.
  • To provide a new tool for analyzing oncogenic kinase activity and drug response.

Main Methods:

  • Development of a novel biosensor system.
  • Utilizing the biosensor to detect Abl kinase activity in live intact cells.
  • Overexpressing a CML model Abl kinase construct in cells for testing.

Main Results:

  • Successfully detected Abl kinase activity using the novel biosensor in live cells.
  • Demonstrated the biosensor's capability to assess inhibitor sensitivity.
  • The methodology proved effective in cells overexpressing a CML model Abl kinase.

Conclusions:

  • The novel biosensor enables detection of Abl kinase activity and inhibitor response in intact cells.
  • This straightforward methodology offers a potential new tool for cancer research.
  • It could aid in understanding and overcoming drug resistance in cancers with oncogenic kinase overexpression.

Related Concept Videos

Matrix-Assisted Laser Desorption Ionization (MALDI)01:08

Matrix-Assisted Laser Desorption Ionization (MALDI)

Matrix-assisted laser desorption ionization (MALDI) is a powerful analytical technique used in mass spectrometry. It enables the identification and characterization of various biomolecules, including proteins, peptides, nucleic acids, and carbohydrates. MALDI is an ionization technique, widely employed in biological and medical research, as well as in fields like pharmacology and biochemistry.The analyte of interest, a biomolecule or a mixture of biomolecules, is mixed with a suitable matrix...
MALDI-TOF Mass Spectrometry01:19

MALDI-TOF Mass Spectrometry

Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...